Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroprotective strategy for femoral nerve block in patients with diabetic peripheral neuropathy
ChiCTR2000030926Phase 4Recruiting
- Sponsor
- Department of Anesthesiology, Beijing Jishuitan Hospital
- Start
- Mar 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine and dexmedetomidine in diabetic polyneuropathy (DPN) (5 arms), sponsored by Department of Anesthesiology, Beijing Jishuitan Hospital. Primary endpoints: motor block, sensory block and 1 more. Started Mar 2019; status: recruiting.
02
Drugs
ropivacainedexmedetomidine
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on ChiCTR2000030926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030926.